Sickle cell patients and their families are speaking out, saying their pain is being treated with a one-size-fits-all ...
Under the agreement, participating states will receive “discounts and rebates” from the drugmakers if the treatments don’t ...
A view of paintings related to sickle cell on a table as Dominique Goodson, who has sickle cell and advocates for awareness about the disease, takes a phone call in her room at her home in the ...
LOS ANGELES (KABC) -- It's been more than a month since the FDA approved two milestone gene-editing treatments for sickle cell disease, but lining up patients for these therapies will be a challenge ...
Medicaid is doing a novel payment system for the new, promising and expensive sickle cell treatment. It may become a model ...
ROANOKE, Va. – Ensuring no one fights alone. The Carilion Clinic Sickle Cell Collaborative is holding a walk to honor sickle cell patients and their caregivers on Saturday. Sickle cell disease is a ...
CHICAGO (WLS) -- Sickle cell anemia disproportionately affects Black people, causing severe pain, potential organ damage and in some cases, death. Many times, only blood transfusions can provide ...
Beam Therapeutics, based in Cambridge, Mass., released early clinical data from its first trial for patients with sickle cell disease that employed a gene editing tool, known as CRISPR. All four ...
Victoria Gray, the first person cured of sickle cell using CRISPR gene editing therapies, spoke in Fargo about her journey and the need to lower the $2M treatment cost. Victoria Gray, cured of sickle ...
Andrea Matthews poses with her son Jonathan Matthews. She started the foundation because her son lives with sickle cell disease. Michelle Parr's sickle cell disease went undiagnosed for 25 years. Her ...
The Sickle Cell Day Unit at the Royal London Hospital in Whitechapel, London, remains under threat following a temporary six-month trial, prompting sustained opposition from patients, families, and ...
NHS Scotland has approved a one-time CRISPR gene therapy for severe sickle cell disease, offering durable reduction in vaso-occlusive crises for eligible patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results